Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Steinberg MH, McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, Ataga K, Swerdlow P, Kutlar A, DeCastro L, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up..

Am J Hematol. 2010 Jun;85(6):403-8. doi: 10.1002/ajh.21699.

2.

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M.

JAMA. 2003 Apr 2;289(13):1645-51. Erratum in: JAMA. 2003 Aug 13;290(6):756.

PMID:
12672732
3.

Clinical follow-up of hydroxyurea-treated adults with sickle cell disease.

Nzouakou R, Bachir D, Lavaud A, Habibi A, Lee K, Lionnet F, Hulin A, Jouault H, Préhu C, Roudot-Thoraval F, Girot R, Galactéros F.

Acta Haematol. 2011;125(3):145-52. doi: 10.1159/000322248. Epub 2010 Dec 24.

PMID:
21196716
4.

Hydroxyurea in sickle cell disease: What will it take to change practice?

Atweh GF.

Am J Hematol. 2010 Jun;85(6):401-2. doi: 10.1002/ajh.21733. No abstract available.

5.

Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization.

Brandow AM, Jirovec DL, Panepinto JA.

Am J Hematol. 2010 Aug;85(8):611-3. doi: 10.1002/ajh.21749. No abstract available.

6.

[Hydroxyurea treatment in patients affected with sickle cell anemia: efficacy and safety].

de Montalembert M.

Transfus Clin Biol. 2008 Feb-Mar;15(1-2):34-8. doi: 10.1016/j.tracli.2008.03.010. Epub 2008 May 21. French.

PMID:
18499496
7.

Survival and mortality among users and non-users of hydroxyurea with sickle cell disease.

de Araujo OM, Ivo ML, Ferreira Júnior MA, Pontes ER, Bispo IM, de Oliveira EC.

Rev Lat Am Enfermagem. 2015 Jan-Feb;23(1):67-73. doi: 10.1590/0104-1169.3385.2526. English, Portuguese, Spanish.

8.

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E.

Blood. 2010 Mar 25;115(12):2354-63. doi: 10.1182/blood-2009-05-221333. Epub 2009 Nov 10.

9.

Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea.

Tripathi A, Jerrell JM, Stallworth JR.

Pediatr Blood Cancer. 2011 Jan;56(1):90-4. doi: 10.1002/pbc.22822. Epub 2010 Oct 4.

PMID:
20922765
10.

Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: two-year results including pharmacokinetics and concomitant hydroxyurea.

Vichinsky E, Torres M, Minniti CP, Barrette S, Habr D, Zhang Y, Files B; study CICL670A2201 investigators..

Am J Hematol. 2013 Dec;88(12):1068-73. doi: 10.1002/ajh.23569. Epub 2013 Sep 19.

11.

Hydroxyurea for children with sickle cell disease.

Heeney MM, Ware RE.

Hematol Oncol Clin North Am. 2010 Feb;24(1):199-214. doi: 10.1016/j.hoc.2009.11.002. Review.

12.

Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP.

Medicine (Baltimore). 1996 Nov;75(6):300-26.

13.

The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients.

Smith WR, Ballas SK, McCarthy WF, Bauserman RL, Swerdlow PS, Steinberg MH, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia..

Pain Med. 2011 May;12(5):697-705. doi: 10.1111/j.1526-4637.2011.01096.x. Epub 2011 Apr 11.

PMID:
21481164
14.

Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease.

de Montalembert M, Belloy M, Bernaudin F, Gouraud F, Capdeville R, Mardini R, Philippe N, Jais JP, Bardakdjian J, Ducrocq R, Maier-Redelsperger M, Elion J, Labie D, Girot R.

J Pediatr Hematol Oncol. 1997 Jul-Aug;19(4):313-8.

PMID:
9256830
15.

Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.

Greenway A, Ware RE, Thornburg CD.

Am J Hematol. 2011 Apr;86(4):357-61. doi: 10.1002/ajh.21986.

16.

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR.

N Engl J Med. 1995 May 18;332(20):1317-22.

17.

Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children.

Strouse JJ, Lanzkron S, Beach MC, Haywood C, Park H, Witkop C, Wilson RF, Bass EB, Segal JB.

Pediatrics. 2008 Dec;122(6):1332-42. doi: 10.1542/peds.2008-0441. Review.

PMID:
19047254
18.

Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea.

Stettler N, McKiernan CM, Melin CQ, Adejoro OO, Walczak NB.

JAMA. 2015 Apr 28;313(16):1671-2. doi: 10.1001/jama.2015.3075. No abstract available.

PMID:
25919532
19.

Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.

Kinney TR, Helms RW, O'Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt OS, Ware RE.

Blood. 1999 Sep 1;94(5):1550-4.

20.

Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: results from the BABY-HUG Phase III Clinical Trial.

McGann PT, Flanagan JM, Howard TA, Dertinger SD, He J, Kulharya AS, Thompson BW, Ware RE; BABY HUG Investigators..

Pediatr Blood Cancer. 2012 Aug;59(2):254-7. doi: 10.1002/pbc.23365. Epub 2011 Oct 19.

Supplemental Content

Support Center